Does Medicare cover blood thinners like Eliquis and Warfarin?

Yes — Medicare Part D covers blood thinners (anticoagulants) including Eliquis (apixaban), Xarelto (rivaroxaban), Pradaxa (dabigatran), Brilinta (ticagrelor), warfarin (Coumadin/Jantoven), and others. Coverage tier and copay vary substantially by plan, and the new 2026 Part D $2,000 out-of-pocket cap dramatically changes the math for high-cost brand-name anticoagulants.

Major brand-name anticoagulants and typical 2026 Part D coverage:

• Eliquis (apixaban): Most plans Tier 3 or Tier 4. Retail price $550–$680/month; typical copay $45–$200/month depending on plan and tier.
• Xarelto (rivaroxaban): Most plans Tier 3 or Tier 4. Retail $550–$650/month.
• Brilinta (ticagrelor): Most plans Tier 3 or Tier 4. Retail $530–$620/month.
• Pradaxa (dabigatran): Most plans Tier 3. Retail $580–$640/month.

Generic warfarin: Available as Tier 1 generic on virtually all Part D plans, $0–$5 copay typical. Requires regular INR monitoring, dietary restrictions, and dose adjustments — but the cost difference vs. DOACs is enormous.

The $2,000 cap impact (2026):

For a member on Eliquis at $150/month copay:
- Without cap (pre-2025): annual cost = $1,800 + potential catastrophic-phase coinsurance = $2,500-$3,500
- With 2026 cap: annual cost capped at $2,000 — once you hit it, $0 for the rest of the year

For a member on multiple expensive drugs including Eliquis:
- The $2,000 cap applies across ALL covered Part D drugs combined
- Eliquis copays count toward the cap
- Hit the cap in February-April typical for high-cost users; rest of year is $0

Medicare Prescription Payment Plan (M3P) — new 2025+:

Let you spread the $2,000 across 12 monthly payments ($166.67/month) instead of paying $150-$200 at the pharmacy each time. Total annual cost is the same; cash flow is smoother.

Selection strategy:

1. List your specific blood thinner. If you're on Eliquis, the question is what each Part D plan charges you. Use Medicare.gov Plan Finder.

1. Compare plans by total annual drug cost (not premium alone). A plan with $40/month premium might charge $200/month for Eliquis; a plan with $60/month premium might charge $40/month. The $20/month premium difference doesn't matter if drug copay differences are $160/month.

1. Watch for tier changes annually. Anticoagulants are common targets for plan formulary changes — your drug could move from Tier 3 to Tier 4 in a new plan year.

1. Generic warfarin remains the cheapest option if your doctor agrees it's clinically appropriate. Saves $1,800+/year vs. DOACs but requires INR monitoring (typically every 4-12 weeks) and dietary management.

Coverage scenarios:

• A-fib patient newly prescribed Eliquis: Most plans cover; expect Tier 3 placement, $50-$150/month copay. Hit $2,000 cap by August on average.
• Long-term warfarin user: Tier 1 generic, $0-$5/month, INR monitoring covered under Part B at no copay (preventive lab).
• Post-stroke or post-DVT short-term anticoagulant: Coverage typically immediate, often without prior authorization.
• Switching from warfarin to a DOAC: Requires PA on most plans; doctor documents reasons (bleeding risk, INR variability, lifestyle compatibility).

Special situations:

• Cost assistance programs: BMS/Pfizer (Eliquis) and other manufacturers offer patient assistance for income-qualified Medicare beneficiaries — but federal anti-kickback laws limit these for Medicare patients. Check Medicare.gov for charitable assistance options.
• Bridging anticoagulation: When stopping anticoagulant for surgery, bridge with shorter-acting agent. Both covered.

What to do next: Call (866) 534-1886. We compare every Part D plan in your ZIP based on your specific anticoagulant + other medications. Free.